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Complex IMitochondria are an essential organelle, not only to the human cell, but to all eukaryotic life. This essentiality
is reﬂected in the large number of mutations in genes encoding mitochondrial proteins that lead to disease.
Aside from their relevance to disease, mitochondria are, given their endosymbiotic origin, very interesting
from an evolutionary point of view. Here, in the year that marks the bicentenary of Darwin's birth and the
150th anniversary of the publication of “On the origin of species” we review approaches that implicitly or
explicitly use evolutionary analyses to ﬁnd new genes involved in mitochondrial disease and to predict their
function and involvement in pathways. We show how the phenotypic spectrum of mitochondrial disease is
linked to the evolutionary origin of mitochondrial proteins, how combinations of evolutionary data and
genomics data have been used to predict the mitochondrial proteome and functional links between the
mitochondrial proteins and how the evolution of the mitochondrial proteome has been used to predict new
mitochondrial disease genes. For the latter we review and reanalyze the eukaryotic evolution of the NADH:
ubiquinone oxidoreductase (complex I) and the proteins involved in its assembly.© 2009 Elsevier B.V. All rights reserved.1. Introduction
Mitochondrial genetic disease affects 1 in 5000 live births, most of
which without a known cure [1]. Although mitochondria carry their
own genome, the large majority of human mitochondrial proteins,
which a recent estimate has put at 1500 [2], are nuclear encoded. This
is reﬂected in patients with mitochondrial disease in which only for
15%–50% of casesmutations inmitochondrial DNA can be identiﬁed [3,
4], and inwhich for a large fraction the responsible gene defect has not
been identiﬁed [5]. The recent progress towards completing the
mammalian mitochondrial proteome [6] and understanding its
functions is therefore essential to battle mitochondrial disease.
Mitochondria are the result of the of the endosymbiosis of an alpha-
proteobacterium with a host cell [7, 8]. This endosymbiosis was
followed by a dramatic turnover of the mitochondrial protein content
within the evolutionary lineages leading to Homo sapiens and Sac-
charomyces cerevisiae [9]. Mitochondria also show a large variation
between the evolutionary lineages. It now appears that all eukaryotic
species known harbor organelles that are evolutionary related to
mitochondria, but that come in various shapes, like anaerobic
mitochondria [10], mitosomes [11–14], hydrogenosomes [15], or
hydrogen producing mitochondria [16, 17]. The proteomic spectrum
of the complexity of the organelles therewith ranges from full ﬂedged
mitochondria in mammals [6], plants [18] and ciliates [19], via31 24 3619395.
n), radek@cmbi.ru.nl
ll rights reserved.mitochondria in which some of the oxidative phosphorylation
complexes have been replaced with non-proton pumping proteins
like in S. cerevisiae [20], Plasmodium falciparum [21], and the hydrogen
producing mitochondrion of Nyctotherus ovalis [16], to mitochondria-
derived organelles that lack oxidative phosphorylation and a genome
altogether, like in Encephalitozoon cuniculi [22, 23], Trichomonas
vaginalis [15, 24], or Entamoeba histolytica [11, 25]. With the increase
in mitochondrial-omics data from model species and the number of
sequenced genomes, approaches that take this evolution implicitly or
explicitly into account are becoming increasingly useful in discovering
genes involved in mitochondrial function and disease. They e.g.
exploit the knowledge about the mitochondrial proteome in yeast to
predict mitochondrial proteins in man, or the concerted loss of
proteins with related function in speciﬁc lineages to predict new
proteins with that function. In this review we will give an overview of
the use of evolutionary analyses in the determination of the
mitochondrial proteome and its function.
2. The mitochondrial proteome
To study mitochondrial proteome evolution and link it to disease
we ﬁrst have to know which proteins it contains. More than 99% of
human mitochondrial proteins are transcribed from the nuclear
genome and imported into the mitochondria [26]. Although the
mitochondrial targeting signal provides a clue for mitochondrial
localization, it has limited sensitivity and accuracy [6] and is
sometimes even missed in the automated gene prediction [27]. Early
genome-wide experimental approaches to elucidate the mitochon-
drial proteome of yeast were based on the expression change
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[28], or on the comparison of the effect of single deletions between
fermentative and respiratory growth [29]. Such approaches do not
only identify mitochondrial proteins, but also non-mitochondrial
proteins that are essential to mitochondrial function, like the
ribonucleotide-diphosphate reductase complex in the nucleus that
affects the mitochondrial genome through alterations of the nucleo-
tide pools [30]. Supporting the relevance of such indirect approaches
is that non-mitochondrial proteins have been implicated in mitochon-
drial disease [31]. Direct assessments of the yeast mitochondrial
proteome have been obtained through mass spectrometry [20, 32]
and epitope tagging combined with microscopy [33, 34]. For
mammals, recent progress in delineating the mitochondrial proteome
was deﬁned by high-throughput studies using proteomics techniques.
Human heart [35], multiple rat tissues [36, 37], mouse liver [38] and
six other murine tissues [39] have been scrutinized for their protein
content with mass spectrometry. All studies go to great lengths to
assure minimal contaminationwith non “sensu stricto”mitochondrial
proteins, like hexokinases that bind on the outer membrane of the
mitochondria [40] and frequently show up in mitochondrial proteo-
mics datasets [41]. This includes combining proteomics data with
mRNA expression patterns [39] and correlation proﬁling, where mass
spectrometric intensity proﬁles from certain marker proteins are used
to deﬁne a consensus proﬁle through a centrifugation gradient [38].
Similarly, enrichment of mitochondrial proteins and depletion of
contaminants in pure mitochondrial puriﬁcations, compared to crude
ones, is used in subtractive proteomics approaches [6]. Nevertheless,
proteomics methods have been estimated to cover no more than 40%
of estimated human mitochondrial proteome, with a false positive
error rate of up to 40% [6]. Integrative approaches, that combine
independent evidence frommultiple sources, stand a better chance of
faithfully representing the mitochondrial proteome. Such approaches
also include evolutionary data. One of them is based on the
evolutionary conservation of subcellular localization and uses the
homology of a human protein to a yeast mitochondrial protein to
predict that the former is mitochondrial as well [41]. With a few
notable exceptions, like the proteins involved in the arginine
metabolism that are mitochondrial in humans [42] and cytosolic in
yeast [43], when the yeast protein is a 1-1 ortholog of human protein,
the mitochondrial localization is indeed conserved in the evolution
between human and yeast (RS and MH unpub. data). In the case of
gene duplications another pattern appears. Glutamate dehydrogenase
1, which has both a cytoplasmatic and a mitochondrial localization,
has been duplicated in the ancestor of the great apes to glutamate
dehydrogenase 2, which has an exclusively mitochondrial localization
[44]. More dramatically, at least 63 human mitochondrial proteins
have arisen through the duplication of a gene that encoded a non-
mitochondrial protein, followed by retargeting of the new protein, e.g.
by the addition of a mitochondrial targeting signal (RS and MH,
submitted). Besides orthology to yeast mitochondrial proteins, also
homology to bacterial proteins has been used to predict mitochondrial
localization, e.g. in the case of frataxin [45] and in large-scale analyses
[41]. It, however, has less predictive value [41] than the mitochondrial
location of a yeast ortholog, which is consistent with the observation
that most of the proteins that are derived from its alpha-proteobac-
terial ancestor of themitochondria, are actually not mitochondrial and
have moved to other parts of the eukaryotic cell [46]. One aspect of
homology basedmethods that is relatively unexploited, is the usage of
proﬁle-based methods that have a much higher sensitivity than the
often used BLAST [47], which does not detect the homology of many
short, rapidly evolving proteins (see below).
Mass spectrometry data have been combined with evolutionary
data, the presence of a computationally predicted mitochondrial
targeting signal, co-expression with other mitochondrial proteins and
the presence of cis-motifs over represented 5′ of genes encoding
mitochondrial proteins [48], to increase the quality of predictions.Each independent data type increases the probability of detecting a
new mitochondrial protein, but also introduces a signiﬁcant amount
of noise. For example, a computational prediction of the targeting
signal has high sensitivity of 60% (60% of all known mitochondrial
proteins are detected) but the false discovery rate can reach 70% (only
30% of the predicted proteins are known to be mitochondrial) [6], and
the predictive value of a cis-motif located in the upstream regions of
genes encoding mitochondrial proteins is rather small, being present
in less than 20% of those genes [41]. Each data type, whether
experimental or computational, has therefore to be evaluated with
respect to its sensitivity and speciﬁcity by comparison with a “golden
standard” of mitochondrial proteins, after which it can be integrated
in a tool like a Bayesian framework [41] or a linear classiﬁer [49].
Recent advances in the mammalian proteome discovery have resulted
in a compendium of 1100 proteins, analyzed with respect to their
protein expression across 14 murine tissues and integrated with other
evidence types in a probabilistic manner [6]. The compendium has
been estimated to cover more than 85% of putative mammalian
mitochondrial proteome, and to contain an estimated 10% false
predictions, a quality far better than achieved by any single
experimental technique on its own. Data integration within a species
and between species has also beenmade accessible through databases
on the web, like Mitop2 [50] and, more recently, MitoMiner [51].
3. Mitochondrial disease phenotype and protein origin
The systematic determination of the mitochondrial proteome,
besides being important for the discovery of new mitochondrial
disease proteins, also allows one to obtain a quantitative overview of
the phenotypic spectrum of mitochondrial disease. We matched the
1100 proteins from MitoCarta [6] against genetic disorders using the
OMIM database [52]. Although there are specialized mitochondrial
disease databases (e.g. http://www.mitoresearch.org/), OMIM has
the advantage that it allows a systematic comparison of mitochondrial
disease with non-mitochondrial disease. Approximately 170 mito-
chondrial proteins in OMIM are involved in ∼160 diseases. They are
part of a recent, manual disease classiﬁcation that classiﬁed the
diseases in OMIMbased on the physiological systemprimarily affected
[53]. Mitochondrial diseases frequently affect numerous physiological
systems at the same time (e.g., MELAS: Mitochondrial myopathy,
Encephalopathy, Lactic acidosis, and Stroke-like episodes), leading to a
relatively large set of “Multiple and Unclassiﬁed” in the classiﬁcation
(Fig. 1). The mitochondrial diseases that can be classiﬁed have a
distinct proﬁle from the other genetic diseases, reﬂecting the
metabolic, energy-converting function of the organelle. Compared to
the complete spectrum of human disease, there is a typical and strong
overrepresentation of metabolic and neuromuscular disease (Fig. 1).
The latter is generally believed to be linked to the high energy demand
of brain andmuscle cells [54]. Vice versa there is under representation
of other classes like developmental, skeletal, connective tissue and
dermatological. For example, out of 37 bone disease genes or 60
cardiovascular disease genes in the classiﬁcation, only a single one
encodes a mitochondrial protein.
Mitochondria are derived from an alpha-proteobacterium that got
engulfed by an ancestor of the eukaryotes. Although the nature of this
host remains hotly debated, e.g. whether it did have an endomem-
brane system and how closely it was related to the Archaea [55, 56],
with respect to the mitochondria, phylogenetic analyses generally
agree that its ancestor was an alpha-proteobacterium [57]. Never-
theless, only a small fraction (15%–20%) of the proteins in current
mitochondria can conﬁdently be traced back to alpha-proteobacteria
[9, 58]. The others do have bacterial homologs that cannot be
conﬁdently linked to alpha-proteobacteria, or appear to be of
eukaryotic origin. With respect to the latter, the mitochondrial
proteins can be traced back to various evolutionary “depths” (Fig. 2).
The largest fraction of these non-bacterial disease genes can be found
Fig. 1. Comparison of the diseases caused by mutations in mitochondrial proteins [6] (left) with disease caused by non-mitochondrial proteins (right). The diseases were manually
classiﬁed by the physiological system primarily affected [53]. Mitochondrial disease shows, compared to non-mitochondrial disease, a typical over representation of metabolic and
neuromuscular disease, as well as a relatively large set of cases in which multiple mutations in systems are affected.
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eukaryotic kingdom, like the Twinkle protein, a helicase responsible
for sensory ataxic neuropathy that is also present in ﬁve of the six
major eukaryotic phyla [59]. Others are of more recent origin, and can
only be found in metazoa, like the apoptosis regulator BCL2; in
vertebrates, like CYP11B1, involved in glucocorticoid-remediable
aldosteronism; or even in amniota, like PANK2 that is involved in
pantothenate kinase-associated neurodegeneration. With respect to
the proteins for which bacterial homologs can be detected, almost half
(51/109) are associated with metabolic disease (Fig. 2). This is
consistent with that most of the proteome of alpha-proteobacterial
origin in current day mitochondria is involved in metabolism and
translation [9]. Vice versa, the genes involved in endocrine disease
originate at the origin of the vertebrates, matching the date of the
origin of the endocrine system. In principle such correlations between
the age of a protein and the disease it is involved in can be used to
predict new candidate genes for mitochondrial disease, although they
would have to be integrated with other types of information to make
the predictions reliable enough for experimental testing.
4. Mitochondrial disease and protein interaction
Aside from comparing the evolutionary origin of proteins with
their disease phenotype, one can also ask whether proteins with
similar functions are associated with similar diseases. Functional
similarities between proteins, either because they perform a similarFig. 2. Phylogenetic origin of proteins associatedwith certain disease classes. To date the
origin of mitochondrial proteins, the appearance of homologs of the gene in the genome
sequences was used in combination with a reference phylogeny of the eukaryotes [91].
In the case of gene duplications, the duplication event was dated using the overlap
between the species that have two copies of the gene [92].function, or because they are part of the same pathways or physically
interact, have been shown to be indicative of their involvement in
similar disease [60], and are used in programs like Endeavour [61] and
Cipher [62] to predict new genes involved in a disease. We analyzed
whether such a correlation can also be speciﬁcally observed for
mitochondrial disease. To cluster mitochondrial proteins with a
similar function we used a hierarchical clustering approach applied
to functionally interacting proteins that has been used by Steinmetz
and co-workers for the mitochondrial proteome of S. cerevisiae [49],
and that is based on both predicted and experimentally determined
protein–protein interactions in STRING [63]. A total of 629 mitochon-
drial human proteins could be placed in functional modules contain-
ing at least ﬁve proteins (Fig. 3). Such clustering separates
mitochondrial proteins into functional modules, and puts these
modules in relation to each other (light gray lines on the Fig. 3). The
ﬁgure shows that proteins in the same functional module appear to be
consistent with respect to the disease type. For example, complex I
and regulation of apoptosis are enriched for neuromuscular disease,
while genes involved in propanoate metabolism and acyl-CoA
dehydrogenation are involved in metabolic disorders. This points to
a correlation between the biological network of proteins on the one
hand and the phenotypic network on the other hand [64]. Addition-
ally, the interconnectivity between proteins may help to identify
appropriate drug targets to reverse the detrimental effects of pathway
perturbation [65]. The assembly of a set of “disease loci”with a typical
mitochondrial phenotype and the combination of several types of data
for mitochondrial localization have been employed to predict new
mitochondrial disease genes [41], including one (MPV17) that was
experimentally corroborated [66].
A second bias that is apparent in Fig. 3 is that for some gene
clusters, like heme synthesis, almost all genes have been found to be
involved in disease while for others, like translation, only very few
have been implicated in disease. This bias is likely to be at least partly
caused by biases in research efforts, e.g. the recognition of a speciﬁc
phenotype linked to the malfunctioning of a known pathway can lead
to the identiﬁcation of other genes from the same pathway in patients
with similar phenotypes. There are, however, also some known biases
for which genes are likely involved in disease. They are e.g. less often
essential than housekeeping genes, but more often essential than the
average gene [67]. Signiﬁcant biases exist also with respect to the
essentiality of mitochondrial proteins. Of the 136 human mitochon-
drial proteins whose mouse orthologs were tested for essentiality by
targeted single-gene knockouts [68], 53% turned out to be lethal,
compared to 43% of non-mitochondrial proteins. When speciﬁcally
Fig. 3.Map of functional modules of humanmitochondria. Proteins were clustered according to their functional gene associations as reported in STRING [63], in a similar fashion as in
ref. [49]. Functional links between proteins are indicated in light gray, and represent both intra- and inter-module relationships. Each cluster was functionally categorized based on
the participation of its proteins in a biological process. Proteins were colored according to the physiological system primarily affected by the disease [53]. Proteins lethal when tested
with a targeted single-gene knockout [68] are encircled. A number of clusters contain a signiﬁcantly higher number of disease genes than expected when disease genes would be
distributed randomly (Pb0.01: propanoate metabolism, DNA replication and fatty acid metabolism) while others contain only a very few disease genes (e.g. translation).
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out to be essential, while of the 77mitochondrial proteins that are not
known to be associated with disease 33 (43%) have lethal knockouts.
Although these differences in essentiality between genes known to be
involved in disease and genes that are not (yet) known to be involved
in disease are signiﬁcant, they are not so large that they have
predictive value on their own.
5. Predicting genes involved in mitochondrial disease from
co-evolution
A very speciﬁc case of exploiting evolutionary data for the
prediction of disease genes is NADH ubiquinone oxidoreductase
(complex I) that catalyzes the ﬁrst step in the oxidative phosphoryla-
tion. The total number of proteins in complex I in mammals is 45 [69],
yet, a large fraction of complex I deﬁciencies are not associated with
mutations in any of the complex I genes. There are however genes that
are required for complex I function without being part of the mature
complex itself: so-called complex I assembly factors. In ﬁnding these
factors, the exploiting of evolution has played a signiﬁcant role.
Complex I has been completely lost six times in the evolution of the
currently sequenced eukaryotes, and partially lost once (Fig. 4). Such
an evolutionary pattern gives a search image to ﬁnd new complex I
assembly factors. This technique, that uses the genomic co-occurrence
of genes or their so-called phylogenetic proﬁles to predict interactions
between their proteins, was proposed in the last decade [70, 71], and
has e.g. been used to correctly predict that frataxin plays a role in iron–
sulfur cluster assembly [72], based on the co-occurrence of the
frataxin gene with iron–sulfur cluster assembly genes. To increase the
speciﬁcity of the predictions that can be achieved with this technique,
the list of co-evolving genes is often combined with other experi-
mental or evolutionary information. Examples are the B17.2L gene
that, besides having the same history as complex I is also a homolog of
a complex I gene, B17.2 [72, 73], and C2Orf56, that like complex I isderived from the alpha-proteobacteria, and has been lost in the same
eukaryotic evolutionary lineages since [74]. Another strategy, the
combining of evolutionary data with data on which proteins are
mitochondrial, has resulted in the discovery of complex I assembly
factor C8Orf38 [6] and C20Orf70 [75], as well as the prediction of a list
of other mitochondrial proteins co-evolving with complex I [6]
including C2Orf56. In one case the speciﬁc research question,
identifying a protein involved in the assembly of iron–sulfur clusters
on complex I, was probed by ﬁnding a homolog of proteins involved in
FeS assembly in the cytosol and examining whether that protein has
the same phylogenetic distribution as complex I [76]. Despite these
success stories, the co-evolutionary patterns are not always perfect.
The IND1 gene, although of ancient eukaryotic origin, cannot be
detected in the Nematodes [76], even though these species have
orthologs of most complex I genes. Furthermore, the recently
discovered complex I assembly factors C6Orf66 [77] and ECSIT [78]
can only be found in metazoa. Although suchmetazoan inventions are
not uncommon for complex I, as ﬁve of its genes only have orthologs
in the metazoa (Fig. 4), they do not provide an efﬁcient search image
as there are many more genes that are metazoan-speciﬁc. Co-
evolutionary studies have successfully been integrated with experi-
mental techniques to ﬁnd new assembly factors, and like those
techniques provide independent, but often not sufﬁcient evidence for
protein function.
6. Mitochondrial proteins and the ﬁnding of distant homologs
Even though homology search by Blast is one of the most
successful tools for protein function prediction, it is known to detect
less than 20% of the known homology relations [47]. More sensitive
approaches, that rely on the comparison of a sequence against an
alignment of related sequences (a so-called sequence proﬁle), or even
the comparison of two proﬁles against each other (proﬁle-to-proﬁle
methods) are able to detect homology between less similar proteins
Fig. 4. Phylogenetic distribution of the 45 mammalian complex I proteins and the currently known assembly factors. Sequence analysis was performed with PSI-Blast [93] and with
HHsearch [82] after the construction of sequence proﬁles of orthologous groups of proteins, and followed by phylogenetic tree construction in cases where there were multiple
homologs per species. The eight complex I assembly factors that have been corroborated experimentally, plus one (C2Orf56/PRO1853) that has been predicted twice [6, 74] but has
not been corroborated are underlined. ⁎NDUFA4 is not widespread among the fungi, but does occur in the Basidiomycetes. The ﬁgure is largely consistent with earlier analyses of the
phylogenetic distribution of complex I subunits [79, 80] with the addition of the homology relations between 1) NUZM and NDUFA7 (see Fig. 5), 2) NDUFC2, NCU01467.1 and
AT4G20150, 3) NDUFB8 and AT5G47570, see also ref. [94], 4) NDUFB2 and AT1G76200, see also ref. [94] and 5) NDUFB4 and AT2G31490, see also ref. [95]. The six losses of complex I
implied in the ﬁgure and in ref. [76], rather than four losses in ref. [6] are the result from the usage of a different, more standard eukaryotic phylogeny in the former.
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themitochondrial proteome suchmethods have been able to establish
homology and orthology relations between the proteins from
different species like complex I [79, 80] or themitochondrial ribosome
[81], allowing the transfer of functional annotation between these
proteins or even the prediction new members of a protein complex.
Two yeast mitochondrial ribosome proteins have distant homologs in
man that have been proposed to be part of the human mitochondrial
ribosome [81]. The development of more sensitive, proﬁle-based
based homology and the sequencing of new genomes that allows the
creation of more accurate sequence proﬁles for protein families,
increases the number of homology relations that can reliably beFig. 5.Multiple sequence alignment of NDUFA7/NUZM family. The ﬁrst 80 amino acids of the
conservation of a short motif N-x-Y-x-x-R-D-x-R-R in both NDUFA7 and NUZM. Alignmentdetected. A typical example is the homology between NUZM and
NDUFA7 that escaped our homology detection in 2005 [79], even
though it is quite obvious in the current alignment (Fig. 5) that was
derived with HHsearch (http://toolkit.tuebingen.mpg.de) [82].
Another example is the homology between the complex I subunits
from mammals NDUFC2, from Neurospora crassa NCU01467.1 [83],
and from Arabidopsis thaliana At4g20150 [80, 84] that has gone
unnoticed in the literature, but is signiﬁcant in HHsearch. All in all,
these results do paint a less patchy evolution of mitochondrial
complexes than previously appreciated, although is has been
suspected that some homology relations did indeed exist but escaped
detection by sequence analysis methods [85]. They do not, however,human NDUFA7 and orthologous sequences from other species are shown. Note the high
between the NDUFA7 and NUZM subfamilies was constructed with HHsearch [82].
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lost a number of times and that this loss can be exploited to ﬁnd new
proteins involved in their function.
7. Outlook
Science is driven by technological advance. The advance in
sequencing technologies [86] will facilitate the sequencing the
complete genome of a patient. In parallel to the advances in
proteomics that will lead to the elucidation of all human mitochon-
drial proteins, we will soon be able to examine all the mitochondrial
protein genes of a patient with a mitochondrial phenotype for
potentially harmful mutations. This will lead to a shift from
predicting disease genes to disease mutations. Also here evolutionary
analyses play a major role, as sequence conservation is standard tool
for predicting which mutations are most harmful, and as such is also
implemented in a disease mutation prediction tool like PolyPhen
[87]. It furthermore challenges us to use evolution to predict the
function of all mitochondrial proteins. Sequencing of new genomes
will uncover more instances of the loss of complex I, allowing a
higher reliability in the prediction of complex I assembly factors.
Furthermore, the sequencing of species that have lost other
mitochondrial complexes and pathways, like complex III in Blasto-
cystis [17] will allow the usage of co-evolution to predict new genes
involved in their function. Nevertheless, while for 8 proteins it has
now been established that they are involved in complex I assembly,
how exactly these proteins function in the complex assembly has for
most not been elucidated. Can we achieve a more speciﬁc type of
function prediction than “this protein is somehow involved in the
assembly of complex I?” Bioinformatics coupled to functional
analyses in the species T. vaginalis [88] and bioinformatic analyses
in Schizosaccharomyces pombe [79] have already shown instances
were one submodule of complex I, consisting of the 24 kDa and 51 kDa
NADH oxidizing subunits, has been maintained while the remainder of
the complex has been lost (see also Fig. 4). The trypanosomatidae
appear to be the ﬁrst eukaryotic species that have lost about half of
complex I [89] (Fig. 4). As these species have retained the matrix
proteins of the bacterial core but not all the membrane proteins, it has
been suggested that they only use complex I to oxidizeNADH, and not to
pump protons [89]. Such unexpected patterns in the evolution of
complexes might be exploited to predict which complex I proteins are
involved in which part of its function. Unexpected patterns in the
evolutionary data, and inconsistencies between evolutionary data and
experimental data, such as the presence of an ortholog of the
mitochondrial DNA-interacting protein ATAD3 [90] in Cryptosporidium
parvum (MH unpub, res.), a species without mitochondrial DNA
challenge us to re-examine all the evidence, and can potentially lead
to a higher resolution description of protein function. For such analyses,
detailed sequence proﬁle-based homology analyses, coupled to phylo-
geny based orthology prediction are essential to assure that paralogs do
not confuse the phylogenetic distribution of a protein [76]. State of the
art theoretical and experimental approaches to characterization of the
mitochondrial proteome coupled to individual detailed experimental
approaches to unravel the speciﬁc functions of the proteins will
ultimately lead to an understanding of how protein malfunction leads
to disease, paving the way for rational drug design [1].
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